【市場調査レポート】プレガバリンAPIのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Pregabalin API Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。プレガバリンAPIのグローバル市場インサイト・予測（～2028年） / Global Pregabalin API Market Insights, Forecast to 2028 / QY2207E02189資料のイメージです。

• レポートコード：QY2207E02189
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、111ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のプレガバリンAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にプレガバリンAPIの世界市場のxxx％を占める「純度≥99％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のプレガバリンAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのプレガバリンAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのプレガバリンAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

プレガバリンAPIのグローバル主要メーカーには、SUANFARMA、VASUDHA PHARMA、Atom Pharma、Sienna Biotec、Kopran、Teva、Afton Pharma、Cadila、Sunshine Pharmaceutical、Hanmi Fine Chemical、Rivocean Jiangsu Pharmaceutical、Hubei Vanz Pharm、Menovo、Saintsun、SyncoZymes、Taian Aidi Biotechnologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

プレガバリンAPI市場は、種類と用途によって区分されます。世界のプレガバリンAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度≥99％、純度≥99.5％

【用途別セグメント】
錠剤、カプセル、経口液

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- プレガバリンAPI製品概要
- 種類別市場（純度≥99％、純度≥99.5％）
- 用途別市場（錠剤、カプセル、経口液）
- 調査の目的
・エグゼクティブサマリー
- 世界のプレガバリンAPI販売量予測2017-2028
- 世界のプレガバリンAPI売上予測2017-2028
- プレガバリンAPIの地域別販売量
- プレガバリンAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別プレガバリンAPI販売量
- 主要メーカー別プレガバリンAPI売上
- 主要メーカー別プレガバリンAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度≥99％、純度≥99.5％）
- プレガバリンAPIの種類別販売量
- プレガバリンAPIの種類別売上
- プレガバリンAPIの種類別価格
・用途別市場規模（錠剤、カプセル、経口液）
- プレガバリンAPIの用途別販売量
- プレガバリンAPIの用途別売上
- プレガバリンAPIの用途別価格
・北米市場
- 北米のプレガバリンAPI市場規模（種類別、用途別）
- 主要国別のプレガバリンAPI市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのプレガバリンAPI市場規模（種類別、用途別）
- 主要国別のプレガバリンAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のプレガバリンAPI市場規模（種類別、用途別）
- 主要国別のプレガバリンAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のプレガバリンAPI市場規模（種類別、用途別）
- 主要国別のプレガバリンAPI市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのプレガバリンAPI市場規模（種類別、用途別）
- 主要国別のプレガバリンAPI市場規模（トルコ、サウジアラビア）
・企業情報
SUANFARMA、VASUDHA PHARMA、Atom Pharma、Sienna Biotec、Kopran、Teva、Afton Pharma、Cadila、Sunshine Pharmaceutical、Hanmi Fine Chemical、Rivocean Jiangsu Pharmaceutical、Hubei Vanz Pharm、Menovo、Saintsun、SyncoZymes、Taian Aidi Biotechnology
・産業チェーン及び販売チャネル分析
- プレガバリンAPIの産業チェーン分析
- プレガバリンAPIの原材料
- プレガバリンAPIの生産プロセス
- プレガバリンAPIの販売及びマーケティング
- プレガバリンAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- プレガバリンAPIの産業動向
- プレガバリンAPIのマーケットドライバー
- プレガバリンAPIの課題
- プレガバリンAPIの阻害要因
・主な調査結果

Market Analysis and Insights: Global Pregabalin API Market
Due to the COVID-19 pandemic, the global Pregabalin API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Purity ≥99% accounting for % of the Pregabalin API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tablet segment is altered to an % CAGR throughout this forecast period.
China Pregabalin API market size is valued at US$ million in 2021, while the US and Europe Pregabalin API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pregabalin API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Pregabalin API include SUANFARMA, VASUDHA PHARMA, Atom Pharma, Sienna Biotec, Kopran, Teva, Afton Pharma, Cadila and Sunshine Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Pregabalin API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Pregabalin API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Pregabalin API Scope and Segment
Pregabalin API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pregabalin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Purity ≥99%
Purity ≥99.5%
Segment by Application
Tablet
Capsule
Oral Liquid
By Company
SUANFARMA
VASUDHA PHARMA
Atom Pharma
Sienna Biotec
Kopran
Teva
Afton Pharma
Cadila
Sunshine Pharmaceutical
Hanmi Fine Chemical
Rivocean Jiangsu Pharmaceutical
Hubei Vanz Pharm
Menovo
Saintsun
SyncoZymes
Taian Aidi Biotechnology
Production by Region
North America
Europe
China
India
South Korea
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Pregabalin API Product Introduction
1.2 Market by Type
1.2.1 Global Pregabalin API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Purity ≥99%
1.2.3 Purity ≥99.5%
1.3 Market by Application
1.3.1 Global Pregabalin API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Oral Liquid
1.4 Study Objectives
1.5 Years Considered
2 Global Pregabalin API Production
2.1 Global Pregabalin API Production Capacity (2017-2028)
2.2 Global Pregabalin API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Pregabalin API Production by Region
2.3.1 Global Pregabalin API Historic Production by Region (2017-2022)
2.3.2 Global Pregabalin API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
2.8 South Korea
3 Global Pregabalin API Sales in Volume & Value Estimates and Forecasts
3.1 Global Pregabalin API Sales Estimates and Forecasts 2017-2028
3.2 Global Pregabalin API Revenue Estimates and Forecasts 2017-2028
3.3 Global Pregabalin API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Pregabalin API Sales by Region
3.4.1 Global Pregabalin API Sales by Region (2017-2022)
3.4.2 Global Sales Pregabalin API by Region (2023-2028)
3.5 Global Pregabalin API Revenue by Region
3.5.1 Global Pregabalin API Revenue by Region (2017-2022)
3.5.2 Global Pregabalin API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Pregabalin API Production Capacity by Manufacturers
4.2 Global Pregabalin API Sales by Manufacturers
4.2.1 Global Pregabalin API Sales by Manufacturers (2017-2022)
4.2.2 Global Pregabalin API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Pregabalin API in 2021
4.3 Global Pregabalin API Revenue by Manufacturers
4.3.1 Global Pregabalin API Revenue by Manufacturers (2017-2022)
4.3.2 Global Pregabalin API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Pregabalin API Revenue in 2021
4.4 Global Pregabalin API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Pregabalin API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Pregabalin API Sales by Type
5.1.1 Global Pregabalin API Historical Sales by Type (2017-2022)
5.1.2 Global Pregabalin API Forecasted Sales by Type (2023-2028)
5.1.3 Global Pregabalin API Sales Market Share by Type (2017-2028)
5.2 Global Pregabalin API Revenue by Type
5.2.1 Global Pregabalin API Historical Revenue by Type (2017-2022)
5.2.2 Global Pregabalin API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Pregabalin API Revenue Market Share by Type (2017-2028)
5.3 Global Pregabalin API Price by Type
5.3.1 Global Pregabalin API Price by Type (2017-2022)
5.3.2 Global Pregabalin API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Pregabalin API Sales by Application
6.1.1 Global Pregabalin API Historical Sales by Application (2017-2022)
6.1.2 Global Pregabalin API Forecasted Sales by Application (2023-2028)
6.1.3 Global Pregabalin API Sales Market Share by Application (2017-2028)
6.2 Global Pregabalin API Revenue by Application
6.2.1 Global Pregabalin API Historical Revenue by Application (2017-2022)
6.2.2 Global Pregabalin API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Pregabalin API Revenue Market Share by Application (2017-2028)
6.3 Global Pregabalin API Price by Application
6.3.1 Global Pregabalin API Price by Application (2017-2022)
6.3.2 Global Pregabalin API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Pregabalin API Market Size by Type
7.1.1 North America Pregabalin API Sales by Type (2017-2028)
7.1.2 North America Pregabalin API Revenue by Type (2017-2028)
7.2 North America Pregabalin API Market Size by Application
7.2.1 North America Pregabalin API Sales by Application (2017-2028)
7.2.2 North America Pregabalin API Revenue by Application (2017-2028)
7.3 North America Pregabalin API Sales by Country
7.3.1 North America Pregabalin API Sales by Country (2017-2028)
7.3.2 North America Pregabalin API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Pregabalin API Market Size by Type
8.1.1 Europe Pregabalin API Sales by Type (2017-2028)
8.1.2 Europe Pregabalin API Revenue by Type (2017-2028)
8.2 Europe Pregabalin API Market Size by Application
8.2.1 Europe Pregabalin API Sales by Application (2017-2028)
8.2.2 Europe Pregabalin API Revenue by Application (2017-2028)
8.3 Europe Pregabalin API Sales by Country
8.3.1 Europe Pregabalin API Sales by Country (2017-2028)
8.3.2 Europe Pregabalin API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Pregabalin API Market Size by Type
9.1.1 Asia Pacific Pregabalin API Sales by Type (2017-2028)
9.1.2 Asia Pacific Pregabalin API Revenue by Type (2017-2028)
9.2 Asia Pacific Pregabalin API Market Size by Application
9.2.1 Asia Pacific Pregabalin API Sales by Application (2017-2028)
9.2.2 Asia Pacific Pregabalin API Revenue by Application (2017-2028)
9.3 Asia Pacific Pregabalin API Sales by Region
9.3.1 Asia Pacific Pregabalin API Sales by Region (2017-2028)
9.3.2 Asia Pacific Pregabalin API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Pregabalin API Market Size by Type
10.1.1 Latin America Pregabalin API Sales by Type (2017-2028)
10.1.2 Latin America Pregabalin API Revenue by Type (2017-2028)
10.2 Latin America Pregabalin API Market Size by Application
10.2.1 Latin America Pregabalin API Sales by Application (2017-2028)
10.2.2 Latin America Pregabalin API Revenue by Application (2017-2028)
10.3 Latin America Pregabalin API Sales by Country
10.3.1 Latin America Pregabalin API Sales by Country (2017-2028)
10.3.2 Latin America Pregabalin API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Pregabalin API Market Size by Type
11.1.1 Middle East and Africa Pregabalin API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Pregabalin API Revenue by Type (2017-2028)
11.2 Middle East and Africa Pregabalin API Market Size by Application
11.2.1 Middle East and Africa Pregabalin API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Pregabalin API Revenue by Application (2017-2028)
11.3 Middle East and Africa Pregabalin API Sales by Country
11.3.1 Middle East and Africa Pregabalin API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Pregabalin API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 SUANFARMA
12.1.1 SUANFARMA Corporation Information
12.1.2 SUANFARMA Overview
12.1.3 SUANFARMA Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 SUANFARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 SUANFARMA Recent Developments
12.2 VASUDHA PHARMA
12.2.1 VASUDHA PHARMA Corporation Information
12.2.2 VASUDHA PHARMA Overview
12.2.3 VASUDHA PHARMA Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 VASUDHA PHARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 VASUDHA PHARMA Recent Developments
12.3 Atom Pharma
12.3.1 Atom Pharma Corporation Information
12.3.2 Atom Pharma Overview
12.3.3 Atom Pharma Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Atom Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Atom Pharma Recent Developments
12.4 Sienna Biotec
12.4.1 Sienna Biotec Corporation Information
12.4.2 Sienna Biotec Overview
12.4.3 Sienna Biotec Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Sienna Biotec Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Sienna Biotec Recent Developments
12.5 Kopran
12.5.1 Kopran Corporation Information
12.5.2 Kopran Overview
12.5.3 Kopran Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Kopran Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Kopran Recent Developments
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Overview
12.6.3 Teva Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Teva Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Teva Recent Developments
12.7 Afton Pharma
12.7.1 Afton Pharma Corporation Information
12.7.2 Afton Pharma Overview
12.7.3 Afton Pharma Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Afton Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Afton Pharma Recent Developments
12.8 Cadila
12.8.1 Cadila Corporation Information
12.8.2 Cadila Overview
12.8.3 Cadila Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Cadila Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Cadila Recent Developments
12.9 Sunshine Pharmaceutical
12.9.1 Sunshine Pharmaceutical Corporation Information
12.9.2 Sunshine Pharmaceutical Overview
12.9.3 Sunshine Pharmaceutical Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Sunshine Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Sunshine Pharmaceutical Recent Developments
12.10 Hanmi Fine Chemical
12.10.1 Hanmi Fine Chemical Corporation Information
12.10.2 Hanmi Fine Chemical Overview
12.10.3 Hanmi Fine Chemical Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Hanmi Fine Chemical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hanmi Fine Chemical Recent Developments
12.11 Rivocean Jiangsu Pharmaceutical
12.11.1 Rivocean Jiangsu Pharmaceutical Corporation Information
12.11.2 Rivocean Jiangsu Pharmaceutical Overview
12.11.3 Rivocean Jiangsu Pharmaceutical Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Rivocean Jiangsu Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Rivocean Jiangsu Pharmaceutical Recent Developments
12.12 Hubei Vanz Pharm
12.12.1 Hubei Vanz Pharm Corporation Information
12.12.2 Hubei Vanz Pharm Overview
12.12.3 Hubei Vanz Pharm Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Hubei Vanz Pharm Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Hubei Vanz Pharm Recent Developments
12.13 Menovo
12.13.1 Menovo Corporation Information
12.13.2 Menovo Overview
12.13.3 Menovo Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Menovo Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Menovo Recent Developments
12.14 Saintsun
12.14.1 Saintsun Corporation Information
12.14.2 Saintsun Overview
12.14.3 Saintsun Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Saintsun Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Saintsun Recent Developments
12.15 SyncoZymes
12.15.1 SyncoZymes Corporation Information
12.15.2 SyncoZymes Overview
12.15.3 SyncoZymes Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 SyncoZymes Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 SyncoZymes Recent Developments
12.16 Taian Aidi Biotechnology
12.16.1 Taian Aidi Biotechnology Corporation Information
12.16.2 Taian Aidi Biotechnology Overview
12.16.3 Taian Aidi Biotechnology Pregabalin API Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Taian Aidi Biotechnology Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Taian Aidi Biotechnology Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Pregabalin API Industry Chain Analysis
13.2 Pregabalin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Pregabalin API Production Mode & Process
13.4 Pregabalin API Sales and Marketing
13.4.1 Pregabalin API Sales Channels
13.4.2 Pregabalin API Distributors
13.5 Pregabalin API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Pregabalin API Industry Trends
14.2 Pregabalin API Market Drivers
14.3 Pregabalin API Market Challenges
14.4 Pregabalin API Market Restraints
15 Key Finding in The Global Pregabalin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Pregabalin API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Purity ≥99%
Table 3. Major Manufacturers of Purity ≥99.5%
Table 4. Global Pregabalin API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Pregabalin API Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Pregabalin API Production by Region (2017-2022) & (Tons)
Table 7. Global Pregabalin API Production Market Share by Region (2017-2022)
Table 8. Global Pregabalin API Production by Region (2023-2028) & (Tons)
Table 9. Global Pregabalin API Production Market Share by Region (2023-2028)
Table 10. Global Pregabalin API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Pregabalin API Sales by Region (2017-2022) & (Tons)
Table 12. Global Pregabalin API Sales Market Share by Region (2017-2022)
Table 13. Global Pregabalin API Sales by Region (2023-2028) & (Tons)
Table 14. Global Pregabalin API Sales Market Share by Region (2023-2028)
Table 15. Global Pregabalin API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Pregabalin API Revenue Market Share by Region (2017-2022)
Table 17. Global Pregabalin API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Pregabalin API Revenue Market Share by Region (2023-2028)
Table 19. Global Pregabalin API Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Pregabalin API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Pregabalin API Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Pregabalin API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Pregabalin API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Pregabalin API Revenue Share by Manufacturers (2017-2022)
Table 25. Pregabalin API Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Pregabalin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Pregabalin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pregabalin API as of 2021)
Table 28. Pregabalin API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Pregabalin API Product Offered
Table 30. Date of Manufacturers Enter into Pregabalin API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Pregabalin API Sales by Type (2017-2022) & (Tons)
Table 33. Global Pregabalin API Sales by Type (2023-2028) & (Tons)
Table 34. Global Pregabalin API Sales Share by Type (2017-2022)
Table 35. Global Pregabalin API Sales Share by Type (2023-2028)
Table 36. Global Pregabalin API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Pregabalin API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Pregabalin API Revenue Share by Type (2017-2022)
Table 39. Global Pregabalin API Revenue Share by Type (2023-2028)
Table 40. Pregabalin API Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Pregabalin API Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Pregabalin API Sales by Application (2017-2022) & (Tons)
Table 43. Global Pregabalin API Sales by Application (2023-2028) & (Tons)
Table 44. Global Pregabalin API Sales Share by Application (2017-2022)
Table 45. Global Pregabalin API Sales Share by Application (2023-2028)
Table 46. Global Pregabalin API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Pregabalin API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Pregabalin API Revenue Share by Application (2017-2022)
Table 49. Global Pregabalin API Revenue Share by Application (2023-2028)
Table 50. Pregabalin API Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Pregabalin API Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Pregabalin API Sales by Type (2017-2022) & (Tons)
Table 53. North America Pregabalin API Sales by Type (2023-2028) & (Tons)
Table 54. North America Pregabalin API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Pregabalin API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Pregabalin API Sales by Application (2017-2022) & (Tons)
Table 57. North America Pregabalin API Sales by Application (2023-2028) & (Tons)
Table 58. North America Pregabalin API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Pregabalin API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Pregabalin API Sales by Country (2017-2022) & (Tons)
Table 61. North America Pregabalin API Sales by Country (2023-2028) & (Tons)
Table 62. North America Pregabalin API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Pregabalin API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Pregabalin API Sales by Type (2017-2022) & (Tons)
Table 65. Europe Pregabalin API Sales by Type (2023-2028) & (Tons)
Table 66. Europe Pregabalin API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Pregabalin API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Pregabalin API Sales by Application (2017-2022) & (Tons)
Table 69. Europe Pregabalin API Sales by Application (2023-2028) & (Tons)
Table 70. Europe Pregabalin API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Pregabalin API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Pregabalin API Sales by Country (2017-2022) & (Tons)
Table 73. Europe Pregabalin API Sales by Country (2023-2028) & (Tons)
Table 74. Europe Pregabalin API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Pregabalin API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Pregabalin API Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Pregabalin API Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Pregabalin API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Pregabalin API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Pregabalin API Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Pregabalin API Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Pregabalin API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Pregabalin API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Pregabalin API Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Pregabalin API Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Pregabalin API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Pregabalin API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Pregabalin API Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Pregabalin API Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Pregabalin API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Pregabalin API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Pregabalin API Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Pregabalin API Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Pregabalin API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Pregabalin API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Pregabalin API Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Pregabalin API Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Pregabalin API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Pregabalin API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Pregabalin API Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Pregabalin API Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Pregabalin API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Pregabalin API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Pregabalin API Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Pregabalin API Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Pregabalin API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Pregabalin API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Pregabalin API Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Pregabalin API Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Pregabalin API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Pregabalin API Revenue by Country (2023-2028) & (US$ Million)
Table 112. SUANFARMA Corporation Information
Table 113. SUANFARMA Description and Major Businesses
Table 114. SUANFARMA Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. SUANFARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. SUANFARMA Recent Development
Table 117. VASUDHA PHARMA Corporation Information
Table 118. VASUDHA PHARMA Description and Major Businesses
Table 119. VASUDHA PHARMA Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. VASUDHA PHARMA Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. VASUDHA PHARMA Recent Development
Table 122. Atom Pharma Corporation Information
Table 123. Atom Pharma Description and Major Businesses
Table 124. Atom Pharma Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. Atom Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Atom Pharma Recent Development
Table 127. Sienna Biotec Corporation Information
Table 128. Sienna Biotec Description and Major Businesses
Table 129. Sienna Biotec Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Sienna Biotec Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Sienna Biotec Recent Development
Table 132. Kopran Corporation Information
Table 133. Kopran Description and Major Businesses
Table 134. Kopran Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Kopran Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kopran Recent Development
Table 137. Teva Corporation Information
Table 138. Teva Description and Major Businesses
Table 139. Teva Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 140. Teva Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Teva Recent Development
Table 142. Afton Pharma Corporation Information
Table 143. Afton Pharma Description and Major Businesses
Table 144. Afton Pharma Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 145. Afton Pharma Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Afton Pharma Recent Development
Table 147. Cadila Corporation Information
Table 148. Cadila Description and Major Businesses
Table 149. Cadila Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 150. Cadila Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Cadila Recent Development
Table 152. Sunshine Pharmaceutical Corporation Information
Table 153. Sunshine Pharmaceutical Description and Major Businesses
Table 154. Sunshine Pharmaceutical Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 155. Sunshine Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Sunshine Pharmaceutical Recent Development
Table 157. Hanmi Fine Chemical Corporation Information
Table 158. Hanmi Fine Chemical Description and Major Businesses
Table 159. Hanmi Fine Chemical Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 160. Hanmi Fine Chemical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hanmi Fine Chemical Recent Development
Table 162. Rivocean Jiangsu Pharmaceutical Corporation Information
Table 163. Rivocean Jiangsu Pharmaceutical Description and Major Businesses
Table 164. Rivocean Jiangsu Pharmaceutical Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 165. Rivocean Jiangsu Pharmaceutical Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Rivocean Jiangsu Pharmaceutical Recent Development
Table 167. Hubei Vanz Pharm Corporation Information
Table 168. Hubei Vanz Pharm Description and Major Businesses
Table 169. Hubei Vanz Pharm Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 170. Hubei Vanz Pharm Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Hubei Vanz Pharm Recent Development
Table 172. Menovo Corporation Information
Table 173. Menovo Description and Major Businesses
Table 174. Menovo Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 175. Menovo Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Menovo Recent Development
Table 177. Saintsun Corporation Information
Table 178. Saintsun Description and Major Businesses
Table 179. Saintsun Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 180. Saintsun Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Saintsun Recent Development
Table 182. SyncoZymes Corporation Information
Table 183. SyncoZymes Description and Major Businesses
Table 184. SyncoZymes Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 185. SyncoZymes Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. SyncoZymes Recent Development
Table 187. Taian Aidi Biotechnology Corporation Information
Table 188. Taian Aidi Biotechnology Description and Major Businesses
Table 189. Taian Aidi Biotechnology Pregabalin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 190. Taian Aidi Biotechnology Pregabalin API Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Taian Aidi Biotechnology Recent Development
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Pregabalin API Distributors List
Table 195. Pregabalin API Customers List
Table 196. Pregabalin API Market Trends
Table 197. Pregabalin API Market Drivers
Table 198. Pregabalin API Market Challenges
Table 199. Pregabalin API Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Pregabalin API Product Picture
Figure 2. Global Pregabalin API Market Share by Type in 2021 & 2028
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity ≥99.5% Product Picture
Figure 5. Global Pregabalin API Market Share by Application in 2021 & 2028
Figure 6. Tablet
Figure 7. Capsule
Figure 8. Oral Liquid
Figure 9. Pregabalin API Report Years Considered
Figure 10. Global Pregabalin API Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Pregabalin API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Pregabalin API Production Market Share by Region (2017-2022)
Figure 13. Global Pregabalin API Production Market Share by Region (2023-2028)
Figure 14. Pregabalin API Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Pregabalin API Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Pregabalin API Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Pregabalin API Production Growth Rate in India (2017-2028) & (Tons)
Figure 18. Pregabalin API Production Growth Rate in South Korea (2017-2028) & (Tons)
Figure 19. Global Pregabalin API Sales 2017-2028 (Tons)
Figure 20. Global Pregabalin API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Pregabalin API Revenue 2017-2028 (US$ Million)
Figure 22. Global Pregabalin API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Pregabalin API Sales Market Share by Region (2017-2022)
Figure 24. Global Pregabalin API Sales Market Share by Region (2023-2028)
Figure 25. North America Pregabalin API Sales YoY (2017-2028) & (Tons)
Figure 26. North America Pregabalin API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Pregabalin API Sales YoY (2017-2028) & (Tons)
Figure 28. Europe Pregabalin API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Pregabalin API Sales YoY (2017-2028) & (Tons)
Figure 30. Asia-Pacific Pregabalin API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Pregabalin API Sales YoY (2017-2028) & (Tons)
Figure 32. Latin America Pregabalin API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Pregabalin API Sales YoY (2017-2028) & (Tons)
Figure 34. Middle East & Africa Pregabalin API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Pregabalin API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Pregabalin API in the World: Market Share by Pregabalin API Revenue in 2021
Figure 37. Pregabalin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Pregabalin API Sales Market Share by Type (2017-2028)
Figure 39. Global Pregabalin API Revenue Market Share by Type (2017-2028)
Figure 40. Global Pregabalin API Sales Market Share by Application (2017-2028)
Figure 41. Global Pregabalin API Revenue Market Share by Application (2017-2028)
Figure 42. North America Pregabalin API Sales Market Share by Type (2017-2028)
Figure 43. North America Pregabalin API Revenue Market Share by Type (2017-2028)
Figure 44. North America Pregabalin API Sales Market Share by Application (2017-2028)
Figure 45. North America Pregabalin API Revenue Market Share by Application (2017-2028)
Figure 46. North America Pregabalin API Sales Share by Country (2017-2028)
Figure 47. North America Pregabalin API Revenue Share by Country (2017-2028)
Figure 48. United States Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Pregabalin API Sales Market Share by Type (2017-2028)
Figure 51. Europe Pregabalin API Revenue Market Share by Type (2017-2028)
Figure 52. Europe Pregabalin API Sales Market Share by Application (2017-2028)
Figure 53. Europe Pregabalin API Revenue Market Share by Application (2017-2028)
Figure 54. Europe Pregabalin API Sales Share by Country (2017-2028)
Figure 55. Europe Pregabalin API Revenue Share by Country (2017-2028)
Figure 56. Germany Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 57. France Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Pregabalin API Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Pregabalin API Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Pregabalin API Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Pregabalin API Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Pregabalin API Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Pregabalin API Revenue Share by Region (2017-2028)
Figure 67. China Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 70. India Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Pregabalin API Sales Market Share by Type (2017-2028)
Figure 77. Latin America Pregabalin API Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Pregabalin API Sales Market Share by Application (2017-2028)
Figure 79. Latin America Pregabalin API Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Pregabalin API Sales Share by Country (2017-2028)
Figure 81. Latin America Pregabalin API Revenue Share by Country (2017-2028)
Figure 82. Mexico Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Pregabalin API Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Pregabalin API Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Pregabalin API Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Pregabalin API Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Pregabalin API Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Pregabalin API Revenue Share by Country (2017-2028)
Figure 91. Turkey Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 93. UAE Pregabalin API Revenue (2017-2028) & (US$ Million)
Figure 94. Pregabalin API Value Chain
Figure 95. Pregabalin API Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

以下、関連資料のご紹介

製薬用紙のグローバル市場インサイト・予測（～2028年）

Global Pharma Grade Paper Market Insights, Forecast to 2028
QY2207E01952 2022年7月 95Pages
新型コロナウイルス感染症のパンデミックにより、世界の製薬用紙の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に製薬用紙の世界市場のxxx％...

製薬用カルナウバロウのグローバル市場インサイト・予測（～2028年）

Global Carnauba Wax Used in Pharma Market Insights, Forecast to 2028
QY2207C0757 2022年7月15日 109Pages
新型コロナウイルス感染症のパンデミックにより、世界の製薬用カルナウバロウの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に製薬用カルナウバ...

世界の製薬用カルミン酸市場予測（～2028年）：カルミン酸含有量：90％以下、カルミン酸含有量：90％以上

Global Pharma Grade Carminic Acid Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E2063 2022年5月 99Pages
製薬用カルミン酸市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。<...

世界の医薬品用カルナバワックス市場予測（～2028年）：T1、T3、T4

Global Carnauba Wax Used in Pharma Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E0793 2022年5月 103Pages
医薬品用カルナバワックス市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供し...

世界の製薬用ワセリン市場予測（～2028年）：白色ワセリン、黄色ワセリン

Global Pharma Grade Petroleum Jelly Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E2065 2022年5月 99Pages
製薬用ワセリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。

フィナステリド経口錠剤のグローバル市場インサイト・予測（～2028年） Finasteride Oral Tablet is a medication used for the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB). Market Analysis and Insights: Global Finasteride Oral Tablet Market Due to the COVID-19 pandemic, the global Finasteride Oral Tablet market size is estimated to be wo…
世界の経口コデイン錠市場予測（～2028年）：単一成分コデイン、多成分薬 The Oral Codeine Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
世界のフィナステリド経口錠剤市場予測（～2028年）：1mg錠、5mg錠 The Finasteride Oral Tablet market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
グルコン酸カルシウム経口液剤のグローバル市場インサイト・予測（～2028年） Calcium gluconate oral solution is indicated for the prevention and treatment of calcium deficiency, such as osteoporosis, hand and foot convulsions, bone hypoplasia, rickets and calcium supplementation in children, pregnant and lactating women, menopausal women and the elderly. Market Analysis and …
世界の線維筋痛症治療薬市場予測（～2028年）：シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他 The Fibromyalgia Therapeutics Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…